Our clinical trials

There are many stages to developing a new medicine or medical procedure that aims to prevent, diagnose, treat or manage prostate cancer. But in most cases, the final step to take these developments from the lab, to the clinic, are clinical trials.

Clinical trials

Risk research

We don’t understand enough about why some men, including black men, are at higher risk of prostate cancer. Understanding more about the genetics of prostate cancer will help us identify men at higher risk, so we can diagnose aggressive cancer earlier and save lives.

Risk research

Focal therapy

Focal therapy could become a new treatment for men with localised, but clinically significant prostate cancer. It involves treating just the cancer, while leaving the rest of the prostate and surrounding tissue intact.

Focal therapy

Recurrence

Recurrent prostate cancer is cancer that has “come back” after a man has had treatment that aimed to cure it. In reality, it hasn’t come back, but never went away in the first place.

Recurrence